8G7-84042-10776
2 vaccinations
7 coded responses
20 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 984 / WA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-03-10
Registered in v-safe
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Fatigue or tirednessFree text: First 4 days had tenderness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
-
2021-03-19
Survey response — day 14, dose 1MedDRA: Night sweats, Pyrexia — Feeling: GoodFree text: For six days total spiked a low grade fever at night from 99. 2 to 101.3. Then seemed to break with night sweating. Normal temps since.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Dose 2 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-02
Survey response — day 7, dose 2MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-17
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Heart rate irregular — Feeling: FairFree text: Fluctuating pulse rate; no pain or dizziness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
- 2021-05-08
-
2021-06-26
Survey response — 3 months, dose 2MedDRA: Oropharyngeal pain, Self-medication — Feeling: GoodFree text: Had a sore throat and slight fever of 100.1 for 2 days. Rested and Tylenol extended 2x daily and felt better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-24
-
2022-03-26
Survey response — 12 months, dose 2MedDRA: Age-related macular degeneration, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with AMD · Healthcare visit (other): Avastin injections in retinal doctor's officeMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): First 4 days had tenderness at injection site
Release 5 — day 14, dose 1
Symptoms: For six days total spiked a low grade fever at night from 99. 2 to 101.3. Then seemed to break with night sweating. Normal temps since.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): No
Release 6 — day 7, dose 2
Systemic reaction (other): No
Release 7 — day 28, dose 2
Symptoms: Fluctuating pulse rate; no pain or dizziness.
Release 9 — 3 months, dose 2
Symptoms: Had a sore throat and slight fever of 100.1 for 2 days. Rested and Tylenol extended 2x daily and felt better.
Release 11 — 12 months, dose 2
Symptoms: Diagnosed with AMD
Healthcare visit (other): Avastin injections in retinal doctor's office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Age-related macular degeneration | · | · | ✓ |
| SD | Heart rate irregular | ✓ | ✓ | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release